CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia Effect of Side Branch Predilation in Coronary Bifurcation Stenting With the Provisional Approach - Results From the COBIS (Coronary Bifurcation Stenting) II Registry Timing and Causes of Unplanned Readmissions After Percutaneous Coronary Intervention: Insights From the Nationwide Readmission Database Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial Quantitative Assessment of Coronary Microvascular Function: Dynamic Single-Photon Emission Computed Tomography, Positron Emission Tomography, Ultrasound, Computed Tomography, and Magnetic Resonance Imaging Rare Genetic Variants Associated With Sudden Cardiac Death in Adults Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk Left Ventricular Assist Devices: Synergistic Model Between Technology and Medicine Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosis
|<<... 60 61 62 63 64 65 66 ...>>|

Consensus2019 Sep 6. pii: S0167-5273(19)32502-1.

JOURNAL：Int J Cardiol. Article Link

A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus

Farmakis D, Agostoni P, Baholli L et al. Keywords: acute heart failure; advanced heart failure; dobutamine; inodilators; inotropes; levosimendan; milrinone; norepinephrine

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top